The Hartford Healthcare Fund Class R5 (HGHTX)

Fund Assets	772.21M
Expense Ratio	1.06%
Min. Investment	$2,000
Turnover	40.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 11, 2025

Previous Close	54.75
YTD Return	11.99%
1-Year Return	35.38%
5-Year Return	18.82%
52-Week Low	40.46
52-Week High	54.75
Beta (5Y)	0.84
Holdings	84
Inception Date	Dec 22, 2006

About HGHTX

The Hartford Mutual Funds, Inc. Hartford Healthcare Fund Class R5 is an open-end mutual fund specializing in the global healthcare sector. Its primary objective is to achieve long-term capital appreciation by investing at least 80% of its assets in equity securities of healthcare-related companies worldwide. Managed jointly by Hartford Funds Management Company, LLC and Wellington Management Company LLP, the fund takes a diversified approach, targeting industries such as pharmaceuticals, biotechnology, medical devices, health information services, and emerging healthcare subsectors. This fund employs fundamental analysis to select both growth and value stocks across large, mid, and small capitalizations. With over 100 holdings and a significant portion of assets allocated to its top holdings, it aims to capture opportunities across the rapidly evolving healthcare landscape. The fund serves investors seeking exposure to the innovations and defensive qualities characteristic of the healthcare industry, benchmarking its performance against indices like the S&P Composite 1500 Health Care Index and the S&P 500 Index. It is notable for its broad sector coverage and global investment mandate.

• Fund Family: Hartford Mutual Funds
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: HGHTX
• Share Class: Class R5
• Index: S&P Composite 1500 Health Care TR

Performance

HGHTX had a total return of 35.38% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.24%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
HGHVX	Class R6	0.94%
HGHFX	Class F	0.94%
HGHIX	Class I	1.05%
HGHYX	Class Y	1.05%

Top 10 Holdings

47.85% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	12.39%
Johnson & Johnson	JNJ	6.59%
Merck & Co., Inc.	MRK	6.55%
UnitedHealth Group Incorporated	UNH	4.68%
AbbVie Inc.	ABBV	3.42%
Intuitive Surgical, Inc.	ISRG	2.98%
Elevance Health, Inc.	ELV	2.94%
CVS Health Corporation	CVS	2.92%
Vertex Pharmaceuticals Incorporated	VRTX	2.71%
Danaher Corporation	DHR	2.66%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 11, 2025	$1.40315	Dec 12, 2025
Dec 27, 2024	$0.07368	Dec 30, 2024
Dec 11, 2024	$1.89862	Dec 12, 2024
Dec 12, 2022	$0.36137	Dec 13, 2022
Dec 10, 2021	$4.37361	Dec 13, 2021
Dec 10, 2020	$5.16605	Dec 11, 2020

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 21, 2026

Data Sources Report a data error